MUC-1 pCAR

N/A

Report date: 2025/01/26 16:19:45

Base Information

Drug NameMUC-1 pCAR

Drug Alias NameAnti-MUC1 CAR T-cell therapy (Leucid Bio)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionMucin-1 modulators

TargetsMucin-1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesLeucid Bio Ltd

China Registration ClassN/A

Develop Information

Active CompaniesLeucid Bio Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A